China's Fanghui Pharma taps US CRO to support international expansion
This article was originally published in Scrip
Executive Summary
With growing demand for their products, a rising number of Chinese pharma companies are looking in earnest at the international expansion of their business. But they all face one big challenge - that of meeting different regulations and standards in various potential export markets.